Molecular mechanisms involved in the antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase.
Manganiello
V C
VC
Laboratory of Cellular Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.
Smith
C J
CJ
Degerman
E
E
Vasta
V
V
Tornqvist
H
H
Belfrage
P
P
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000502:physiology*; D000273:Adipose Tissue / Q000166:cytology / Q000201:enzymology*; D000818:Animals; D006152:Cyclic GMP / Q000378:metabolism; D004789:Enzyme Activation / Q000502:physiology; D007328:Insulin / Q000502:physiology*; D008066:Lipolysis / Q000502:physiology*; D010766:Phosphorylation; D015290:Second Messenger Systems / Q000502:physiology
D007328:Insulin; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D006152:Cyclic GMP